Conference call with CEO Dr. Marianne De Backer to be held on November 5 at 10:30 am. Webcast Link
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VIR:
- Biotech Alert: Searches spiking for these stocks today
- Vir Biotechnology price target lowered to $26 from $28 at Barclays
- U.S. drugmakers shifting away from Chinese supply-chain partners, WSJ says
- Vir Biotechnology Reports Q3 2024 Financial Results
- Vir Biotechnology reports Q3 EPS ($1.56), consensus ($1.05)